Structures by: Vasylyeva V.
Total: 46
HHU-1
C18H18Co4N6O7
CrystEngComm (2013) 15, 45 9757
a=20.1090(7)Å b=20.1090(7)Å c=20.1090(7)Å
α=90.00° β=90.00° γ=90.00°
HHU-2
C18H18N6O7Zn4
CrystEngComm (2013) 15, 45 9757
a=20.071(3)Å b=20.071(3)Å c=20.071(3)Å
α=90.00° β=90.00° γ=90.00°
HHU-3
C36H20Co4N6O7
CrystEngComm (2013) 15, 45 9757
a=14.242(3)Å b=14.278(3)Å c=14.332(4)Å
α=90.00° β=90.00° γ=90.00°
Λ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn
CrystEngComm (2018) 20, 33 4724
a=9.9154(8)Å b=9.9154(8)Å c=21.343(2)Å
α=90.00° β=90.00° γ=90.00°
Λ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn1
CrystEngComm (2018) 20, 33 4724
a=9.9138(3)Å b=9.9138(3)Å c=21.3276(8)Å
α=90.00° β=90.00° γ=90.00°
Λ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn1
CrystEngComm (2018) 20, 33 4724
a=9.9041(3)Å b=9.9041(3)Å c=21.3545(7)Å
α=90.00° β=90.00° γ=90.00°
Λ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn
CrystEngComm (2018) 20, 33 4724
a=9.8663(6)Å b=9.8663(6)Å c=21.1146(17)Å
α=90° β=90° γ=90°
Δ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn1
CrystEngComm (2018) 20, 33 4724
a=9.9077(12)Å b=9.9077(12)Å c=21.330(3)Å
α=90.00° β=90.00° γ=90.00°
Λ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn
CrystEngComm (2018) 20, 33 4724
a=9.8592(4)Å b=9.8592(4)Å c=21.1220(10)Å
α=90° β=90° γ=90°
Δ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn
CrystEngComm (2018) 20, 33 4724
a=9.8258(19)Å b=9.8258(19)Å c=21.005(5)Å
α=90.00° β=90.00° γ=90.00°
Δ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn
CrystEngComm (2018) 20, 33 4724
a=9.8329(12)Å b=9.8329(12)Å c=21.061(2)Å
α=90.00° β=90.00° γ=90.00°
(η^5^pentamethylcyclopentadienyl)- (methyl 1-butyl-2-phenyl-benzimidazole carboxylate-κC,N)- chlorido-iridium(III)
C29H34ClIrN2O2
Chem.Commun. (2013) 49, 11533
a=12.1557(7)Å b=14.0158(8)Å c=15.6731(9)Å
α=90.00° β=90.00° γ=90.00°
C19H25AuBr3N3O3
C19H25AuBr3N3O3
Dalton Transactions (2009) 35 7063
a=8.452(4)Å b=9.212(4)Å c=15.756(7)Å
α=90.00° β=92.894(9)° γ=90.00°
C17H16AuBr3N2
C17H16AuBr3N2
Dalton Transactions (2009) 35 7063
a=9.6826(5)Å b=12.2416(4)Å c=20.3950(8)Å
α=90.00° β=91.488(4)° γ=90.00°
Iodopentafluorobenzene and pyridine (1:1)
C6F5I,C5H5N
CrystEngComm (2016) 18, 13 2247
a=11.9726(5)Å b=9.2769(4)Å c=11.5812(5)Å
α=90° β=112.372(2)° γ=90°
Iodopentafluorobenzene 3-methylpyridine
C6F5I,C6H7N
CrystEngComm (2016) 18, 13 2247
a=8.0031(4)Å b=12.0310(6)Å c=13.4501(6)Å
α=90° β=100.731(2)° γ=90°
Bromopentafluorobenzene pyridine
C6BrF5,C5H5N
CrystEngComm (2016) 18, 13 2247
a=8.8544(4)Å b=9.3356(4)Å c=14.0154(6)Å
α=90° β=101.4780(10)° γ=90°
Iodopentafluorobenzene tetramethylethylenediamine
C6F5I,C6H16N2
CrystEngComm (2016) 18, 13 2247
a=11.7434(7)Å b=5.8599(3)Å c=16.7329(10)Å
α=90° β=99.173(2)° γ=90°
C13H11MnO6
C13H11MnO6
Dalton Transactions (2010) 39, 10 2536-2545
a=6.435(3)Å b=19.001(9)Å c=10.920(6)Å
α=90.00° β=100.964(9)° γ=90.00°
C16H9MnO6
C16H9MnO6
Dalton Transactions (2010) 39, 10 2536-2545
a=17.398(8)Å b=7.379(3)Å c=11.634(5)Å
α=90.00° β=103.950(10)° γ=90.00°
C16H9MnO6
C16H9MnO6
Dalton Transactions (2010) 39, 10 2536-2545
a=11.745(2)Å b=10.670(2)Å c=13.424(3)Å
α=90.00° β=113.63(3)° γ=90.00°
C16H9MnO6
C16H9MnO6
Dalton Transactions (2010) 39, 10 2536-2545
a=6.3640(12)Å b=7.0047(13)Å c=18.316(3)Å
α=90.874(6)° β=97.733(5)° γ=114.416(4)°
Λ-Bis{(R)-N-(1-phenylethyl)-2-oxo-1-naphthaldiminato- κ^2^N,O}copper(II)
C38H32CuN2O2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 8 3313-3329
a=10.6824(10)Å b=15.2673(13)Å c=9.6381(7)Å
α=90.00° β=90.00° γ=90.00°
Δ-Bis{(R)-N-(1-phenylethyl)-2-oxo-1-naphthaldiminato- κ^2^N,O}copper(II)
C38H32CuN2O2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 8 3313-3329
a=10.6662(16)Å b=15.3354(19)Å c=9.764(3)Å
α=90.00° β=90.00° γ=90.00°
Δ-Bis{(R)-N-(1-phenylethyl)-2-oxo-1-naphthaldiminato- κ^2^N,O}copper(II)
C38H32CuN2O2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 8 3313-3329
a=10.6477(14)Å b=15.3321(15)Å c=9.7742(19)Å
α=90.00° β=90.00° γ=90.00°
Δ-Λ-rac-Bis{(R)-N-1-(3-methoxyphenyl)ethyl-2-oxo-1-naphthaldiminato- κ^2^N,O}copper(II)
C40H36CuN2O4
Dalton transactions (Cambridge, England : 2003) (2014) 43, 8 3313-3329
a=10.4041(8)Å b=12.3307(9)Å c=13.4434(11)Å
α=89.643(4)° β=83.777(4)° γ=74.684(4)°
Δ-Λ-rac-Bis{(R)-N-1-(3-methoxyphenyl)ethyl-2-oxo-1-naphthaldiminato- κ^2^N,O}copper(II)
C40H36CuN2O4
Dalton transactions (Cambridge, England : 2003) (2014) 43, 8 3313-3329
a=10.3705(13)Å b=12.2802(16)Å c=13.3595(16)Å
α=88.882(9)° β=83.365(9)° γ=74.444(8)°
Λ-rac-Bis{(R)-N-1-(4-bromophenyl)ethyl-2-oxo-1-naphthaldiminato-κ^2^N,O}copper(II)
C38H30Br2CuN2O2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 8 3313-3329
a=16.146(5)Å b=5.602(3)Å c=17.357(6)Å
α=90.00° β=99.10(3)° γ=90.00°
Tetra(4-cyanophenyl)ethylene
C30H16N4
Chem.Commun. (2013) 49, 3961
a=22.0767(8)Å b=22.0767(8)Å c=21.1707(10)Å
α=90.00° β=90.00° γ=90.00°
1,2-Dibromotetrafluorobenzene N-Methylacetamide
(C6Br2F4),(C3H7NO)
CrystEngComm (2014) 16, 35 8102
a=7.5319(13)Å b=20.560(3)Å c=8.9505(14)Å
α=90.00° β=114.813(8)° γ=90.00°
1,3-Dibromotetrafluorobenzene N-Methylacetamide
(C6Br2F4),(C3H7NO)
CrystEngComm (2014) 16, 35 8102
a=7.7932(6)Å b=19.6616(14)Å c=8.8023(6)Å
α=90.00° β=115.553(4)° γ=90.00°
1,4-Dibromotetrafluorobenzene N-Methylacetamide
(C6Br2F4),(C3H7NO)
CrystEngComm (2014) 16, 35 8102
a=5.8653(3)Å b=9.0752(5)Å c=22.3773(13)Å
α=90.00° β=95.126(3)° γ=90.00°
1,2-Diiodotetrafluorobenzene N-Methylacetamide
(C6I2F4),(C3H7NO)
CrystEngComm (2014) 16, 35 8102
a=7.2201(3)Å b=8.6847(3)Å c=21.5893(8)Å
α=85.660(2)° β=81.022(2)° γ=74.403(2)°
1,3-Diiodotetrafluorobenzene N-Methylacetamide
(C6I2F4),(C3H7NO)
CrystEngComm (2014) 16, 35 8102
a=8.0655(5)Å b=18.2945(10)Å c=9.1049(5)Å
α=90.00° β=105.695(3)° γ=90.00°
1,4-Diiodotetrafluorobenzene N-Methylacetamide
(C6F4I2),(C3H7NO)
CrystEngComm (2014) 16, 35 8102
a=21.263(9)Å b=4.7949(19)Å c=12.348(6)Å
α=90° β=91.64(2)° γ=90°
N-methylacetamide
C3H7NO
CrystEngComm (2014) 16, 35 8102
a=9.6481(12)Å b=6.3391(8)Å c=7.1825(9)Å
α=90.00° β=90.00° γ=90.00°
Bis{(R)-N-phenylethyl-2-oxo-1-naphthaldiminato-κ^2^N,O}-nickel(II)
C38H32N2NiO2
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 667-680
a=9.5282(16)Å b=15.355(3)Å c=20.655(4)Å
α=90° β=90.146(7)° γ=90°
Bis{(S)-N-phenylethyl-2-oxo-1-naphthaldiminato-κ^2^N,O}nickel(II)
C38H32N2NiO2
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 667-680
a=9.5328(9)Å b=15.2970(16)Å c=20.560(2)Å
α=90° β=90.192(6)° γ=90°
C42H34Ag2Cl2Mn3N12O4
C42H34Ag2Cl2Mn3N12O4
Dalton transactions (Cambridge, England : 2003) (2014) 43, 31 11925-11935
a=10.7323(8)Å b=12.8099(10)Å c=17.3311(13)Å
α=90.00° β=102.411(5)° γ=90.00°
C32H30Ag2Cl2Mn3N12O4,2(CH4O)
C32H30Ag2Cl2Mn3N12O4,2(CH4O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 31 11925-11935
a=7.6594(5)Å b=8.3378(5)Å c=18.1442(12)Å
α=90.522(3)° β=91.722(3)° γ=107.291(3)°
Phomoxanthone A
C38H38O16
Journal of Organic Chemistry (2013) 78, 12409-12425
a=10.6741(8)Å b=12.3578(9)Å c=15.4377(11)Å
α=90.00° β=98.518(3)° γ=90.00°
1-ethyl-3-methylimidazolium tetrachloroferrat(III)
C6H11Cl4FeN2
Crystal Growth & Design (2011) 11, 6 2564
a=9.4124(19)Å b=14.645(3)Å c=12.444(4)Å
α=90.00° β=129.841(18)° γ=90.00°
C6H11Cl4FeN2
C6H11Cl4FeN2
Crystal Growth & Design (2011) 11, 6 2564
a=6.1337(12)Å b=14.362(3)Å c=7.1111(14)Å
α=90.00° β=91.33(3)° γ=90.00°
C7H4FN
C7H4FN
Crystal Growth & Design (2010) 10, 10 4250
a=11.094(7)Å b=7.803(3)Å c=14.174(9)Å
α=90.00° β=90.00° γ=90.00°
C28H12F4N4
C28H12F4N4
Crystal Growth & Design (2010) 10, 10 4250
a=7.1005(14)Å b=13.201(3)Å c=7.0522(14)Å
α=90.00° β=115.11(3)° γ=90.00°
Λ-Bis{(R)-N-(1-phenylethyl)-2-oxo-1-naphthaldiminato- κ^2^N,O}copper(II)
C38H32CuN2O2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 8 3313-3329
a=10.7155(5)Å b=15.2302(8)Å c=9.5786(5)Å
α=90.00° β=90.00° γ=90.00°